615 related articles for article (PubMed ID: 21372215)
21. Genome-wide transcriptome profile of the human osteosarcoma Sa OS and U-2 OS cell lines.
Trougakos IP; Chondrogianni N; Amarantos I; Blake J; Schwager C; Wirkner U; Ansorge W; Gonos ES
Cancer Genet Cytogenet; 2010 Jan; 196(2):109-18. PubMed ID: 20082845
[TBL] [Abstract][Full Text] [Related]
22. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.
Luu HH; Zhou L; Haydon RC; Deyrup AT; Montag AG; Huo D; Heck R; Heizmann CW; Peabody TD; Simon MA; He TC
Cancer Lett; 2005 Nov; 229(1):135-48. PubMed ID: 16157226
[TBL] [Abstract][Full Text] [Related]
24. Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene.
Zucchini C; Bianchini M; Valvassori L; Perdichizzi S; Benini S; Manara MC; Solmi R; Strippoli P; Picci P; Carinci P; Scotlandi K
Bone; 2004 Apr; 34(4):672-9. PubMed ID: 15050898
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
26. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
[TBL] [Abstract][Full Text] [Related]
27. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
29. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.
Mori K; Berreur M; Blanchard F; Chevalier C; Guisle-Marsollier I; Masson M; Rédini F; Heymann D
Oncol Rep; 2007 Dec; 18(6):1365-71. PubMed ID: 17982618
[TBL] [Abstract][Full Text] [Related]
30. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
32. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
33. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
[TBL] [Abstract][Full Text] [Related]
35. Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines.
Zucchini C; Rocchi A; Manara MC; De Sanctis P; Capanni C; Bianchini M; Carinci P; Scotlandi K; Valvassori L
Int J Oncol; 2008 Jan; 32(1):17-31. PubMed ID: 18097539
[TBL] [Abstract][Full Text] [Related]
36. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
37. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.
de Nigris F; Rossiello R; Schiano C; Arra C; Williams-Ignarro S; Barbieri A; Lanza A; Balestrieri A; Giuliano MT; Ignarro LJ; Napoli C
Cancer Res; 2008 Mar; 68(6):1797-808. PubMed ID: 18339860
[TBL] [Abstract][Full Text] [Related]
38. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone.
Hattinger CM; Tarkkanen M; Benini S; Pasello M; Stoico G; Bacchini P; Knuutila S; Scotlandi K; Picci P; Serra M
Eur J Cell Biol; 2004 Sep; 83(9):483-91. PubMed ID: 15540465
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
